(Q74608106)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-Hodgkin's lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

R Nair

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

G Ramakrishnan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

N N Nair

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

T K Saikia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

P M Parikh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S R Joshi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

C S Soman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M Mukhadan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

K T Dinshaw

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

S H Advani

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

2282-2288

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

The anthracycline antineoplastic drugs

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2282%3A%3AAID-CNCR26%3E3.0.CO%3B2-P

Efficacy and cost of cardiac monitoring in patients receiving doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2282%3A%3AAID-CNCR26%3E3.0.CO%3B2-P

Reduced cardiotoxicity of doxorubicin delivered on a weekly schedule. Assessment by endomyocardial biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2282%3A%3AAID-CNCR26%3E3.0.CO%3B2-P

Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2282%3A%3AAID-CNCR26%3E3.0.CO%3B2-P

A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2282%3A%3AAID-CNCR26%3E3.0.CO%3B2-P

MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2282%3A%3AAID-CNCR26%3E3.0.CO%3B2-P

Prospective evaluation of doxorubicin-induced cardiomyopathy resulting from postsurgical adjuvant treatment of patients with soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2282%3A%3AAID-CNCR26%3E3.0.CO%3B2-P

Doxorubicin cardiotoxicity: assessment of late left ventricular dysfunction by radionuclide cineangiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2282%3A%3AAID-CNCR26%3E3.0.CO%3B2-P

Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2282%3A%3AAID-CNCR26%3E3.0.CO%3B2-P

Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2282%3A%3AAID-CNCR26%3E3.0.CO%3B2-P

MACOP-B treatment in diffuse large-cell lymphoma: identification of prognostic groups in an Italian multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980601%2982%3A11%3C2282%3A%3AAID-CNCR26%3E3.0.CO%3B2-P

10.1002/(SICI)1097-0142(19980601)82:11<2282::AID-CNCR26>3.0.CO;2-P

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9610711%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference